摘要Cancer metabolic reprogramming has been considered an emerging hallmark in tumorigenesis and the antitumor immune response.Like cancer cells,immune cells within the tumor microenvironment or premetastatic niche also undergo extensive metabolic reprogramming,which profoundly impacts anti-tumor immune responses.Numerous evidence has illuminated that immunosuppressive TME and the metabolites released by tumor cells,including lactic acid,Prostaglandin E2(PGE2),fatty acids(FAs),cholesterol,D-2-Hydroxyglutaric acid(2-HG),adenosine(ADO),and kynurenine(KYN)can contribute to CD8+T cell dysfunction.Dynamic alterations of these metabolites between tumor cells and immune cells can similarly initiate metabolic competition in the TME,leading to nutrient deprivation and subsequent microenvironmental acidosis,which impedes immune response.This review summarizes the new landscape beyond the classical metabolic pathways in tumor cells,highlighting the pivotal role of metabolic disturbance in the immunosuppressive microenvironment,especially how nutrient deprivation in TME leads to metabolic reprogramming of CD8+T cells.Likewise,it emphasizes the current therapeutic targets or strategies related to tumor metabolism and immune response,providing therapeutic benefits for tumor immunotherapy and drug development in the future.